Results 171 to 180 of about 346,370 (297)

The destruction of Gaza: Satellite measurements of the economic cost of war. [PDF]

PNAS Nexus
Rinaldo D, Alazzeh R, Arcand JL, Scher C, Van Den Hoek J.   +4 more
europepmc   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

A social media driven model for evaluating coupled flood damage and resilience at a fine scale. [PDF]

Sci Rep
Sun D, Mi X, Zhang Z, Guo C, Chenyan T, Zhao S.   +5 more
europepmc   +1 more source

Single-crystals as an indicator of fatigue damage [PDF]

International Journal of Fatigue, 1993
openaire   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Exploring opportunities to integrate climate change into Gross National Happiness for Bhutan and its application for global wellbeing-centred Climate Resilient Development. [PDF]

Environ Manage
Dorji T, Morrison-Saunders A, Blake D.
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Acoustic-Emission-Based Multiscale Tensile Constitutive Model for Ultra-High-Performance Concrete Considering Steel-Fiber Parameters and Beam-Scale Validation. [PDF]

Materials (Basel)
Bao Z, Wang Q, Deng J, Zhang M.
europepmc   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

Assessment of the efficiency of new regenerative gel and spray in experimental model systems. [PDF]

BMC Pharmacol Toxicol
Bezdieniezhnykh N, Lykhova O, Borshchevska M, Goy A, Saulenko K, Kozak T, Kukurudza D, Kruglov Y, Borshchevskiy G, Buchynska L.   +9 more
europepmc   +1 more source